Recent Finacing
Recent Raise
Imagine Pharma develops IMG-1 polypeptide platforms for oral delivery, therapeutics, and regenerative medicine, advancing oral EPO/GLP‑1 programs, commercial supplements, and operating an NIDDK‑approved islet isolation services center.